The Big Pharma Takeover of Medical Cannabis #infographic

The Big Pharma Takeover of Medical Cannabis
As evidence of cannabis’ many advantages mounts, so does the activity from the international pharmaceutical industry, regarded as Big Pharma. The entrance of such behemoths will radically transform the cannabis industry—once heavily stigmatized, it is now a probably game-changing source of boom for limitless companies.

Today’s infographic comes to us from CB2 Insights, and explores how and why the notorious Big Pharma are interested in the nascent cannabis industry.

The term refers to some of the biggest pharmaceutical groups in the world, viewed particularly influential as a group. To provide a feel of their sheer size, the market cap of the top 10 Big Pharma companies is $1.7 trillion—Johnson & Johnson being the largest, with a market capitalization of $374 billion.

So far, Big Pharma has watched the hashish enterprise from the sidelines, deterred with the aid of regulatory concerns. What we are seeing now is the sound asleep giant’s takeover slowly intensifying as more patents, partnerships, and subsidized clinical trials come to fruition.

The cannabis plant has been used in medication for 6,000 years. However, there is still sizeable debate around the position it plays in healthcare today. There are presently nearly 400 active and completed clinical trials worldwide surrounding cannabidiol (CBD), a type of cannabinoid that makes up 40% of the hashish plant’s extract.

The Big Pharma Takeover of Medical Cannabis #infographic

Sourcewww.visualcapitalist.com

Share This Infographic On Your Site

The Big Pharma Takeover of Medical Cannabis #infographic The Big Pharma Takeover of Medical Cannabis #infographic Reviewed by Ali Saeed on August 14, 2019 Rating: 5

No comments:

Powered by Blogger.